Shandong Weigao Medical Polymer Debt to Equity Ratio 2012-2024 | SHWGF
Current and historical debt to equity ratio values for Shandong Weigao Medical Polymer (SHWGF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Shandong Weigao Medical Polymer debt/equity for the three months ending June 30, 2024 was 0.00.
| Shandong Weigao Medical Polymer Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $1.37B | $3.40B | 0.40 |
| 2014-06-30 | $0.36B | $1.51B | 0.24 |
| 2013-12-31 | $0.36B | $1.47B | 0.25 |
| 2013-06-30 | $0.28B | $1.51B | 0.18 |
| 2012-12-31 | $0.25B | $1.42B | 0.18 |
| 2012-06-30 | $0.20B | $1.36B | 0.15 |
| 2011-12-31 | $0.18B | $1.27B | 0.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
| Boston Scientific (BSX) | United States | $151.436B | 37.91 |
| Stryker (SYK) | United States | $144.721B | 30.26 |
| EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
| Medtronic (MDT) | Ireland | $110.247B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.320B | 28.03 |
| Agilent Technologies (A) | United States | $32.988B | 21.51 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Terumo (TRUMY) | Japan | $26.976B | 35.04 |
| Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
| Insulet (PODD) | United States | $21.652B | 84.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
| Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
| Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
| Perrigo (PRGO) | Ireland | $3.636B | 9.22 |
| Haemonetics (HAE) | United States | $3.462B | 15.77 |
| Envista Holdings (NVST) | United States | $3.203B | 26.62 |
| ICU Medical (ICUI) | United States | $3.152B | 23.24 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
| AtriCure (ATRC) | United States | $1.579B | 0.00 |
| Acuren (TIC) | United States | $1.283B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
| Neogen (NEOG) | United States | $1.035B | 13.25 |
| Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.853B | 8.59 |
| Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| Evolus (EOLS) | United States | $0.605B | 0.00 |
| Owens & Minor (OMI) | United States | $0.562B | 4.67 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
| Valneva SE (VALN) | France | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Quanterix (QTRX) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.95 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.45 |
| TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 61.29 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.03 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |